Our History & Milestones
Discover the Ferring story
The development of Ferring is the story of people and peptides. It is about the far-reaching vision of groundbreaking scientists to harness the fundamental role of peptide hormones in controlling many of the body’s key processes to develop medicine on the body’s own terms. And, it is about the vision of entrepreneurs with a spirit of adventure to make these medicines available throughout the globe.
Acquisition of Cytokine-
Acquisition of Cytokine PharmaSciences Inc. (CPSI) and its subsidiary, Controlled Therapeutics Scotland (CTS). The new entity called Ferring Controlled Therapeutics will continue its manufacturing activities in Scotland.
Ferring celebrated its 60th anniversary-
Ferring was founded in 1950 and celebrated its 60th anniversary in 2010. The company has evolved from a small 2-people enterprise to a now strong player in the pharmaceutical field. It is present on all continents.
Launch of FIRMAGON-
Launch of FIRMAGON® (degarelix), a GnRH blocker for advanced hormone-dependent prostate cancer.